One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-151042
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
Affiliation: The University of Texas MD Anderson Cancer Center, Novartis (United States), Australian Centre for HIV and Hepatitis Virology Research, Servier (France), Plateforme Technologique d'Innovation Biomédicale, Medical University of Białystok, Institut des Hautes Études Scientifiques, Monash University, The Alfred Hospital, Novartis (Switzerland)Combination Therapy of FLT3 Tyrosine Kinase Inhibitors and BH3 Mimetics Targeting Antiapoptotic MCL-1 Synergistically Eliminates FLT3-ITD Acute Myeloid Leukemia Cells in Vitro and In Vivo
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
